Kynam Trims Syndax Stake With $8.18 Million Q4 Sale Disclosed in SEC Filing

The remaining holding stayed sizable within the portfolio following a rally that lifted the quarter-end value.

Overview

A February 17, 2026 SEC filing shows Kynam Capital sold 469,041 Syndax shares in Q4 2025, an estimated $8.18 million based on the quarter’s average price.
Post-sale, Syndax accounted for 10.81% of Kynam’s reportable 13F assets under management.
The fund’s quarter-end Syndax position value increased by $38.07 million, reflecting both trading and share-price gains.
Syndax shares were $24.23 as of Friday, up about 72% over the past year.
Syndax reported roughly $172 million in revenue last year, including about $124.8 million from Revuforj, and a full-year net loss near $285 million, with the Yahoo Finance analysis characterizing Kynam’s move as a portfolio rebalance rather than an exit.